title: Chronic myelogenous leukemia evolving after treatment of multiple myeloma.
authors.affiliation: Otto-von-Guericke University Medical Center Magdeburg.
authors.forename: Denise
authors.initials: D
authors.lastname: Wolleschak
authors.affiliation: University Hospital Jena.
authors.forename: Florian H
authors.initials: FH
authors.lastname: Heidel
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology; D000069286:Bortezomib / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D000069286:Bortezomib; D003907:Dexamethasone; D000068877:Imatinib Mesylate